Skip to main content
AMP 2023 Annual Meeting & Expo Main banner
Final Program


Icon Legend
Presentation Icons
Platinum Award
Platinum Award
Gold Award
Gold Award
Silver Award
Silver Award
Bronze Award
Bronze Award

    Andreas von Deimling, MD (he/him/his)

    Director Dept Neuropathology (University Hospital Heidelberg), and director CCU Neuropathology (DKFZ)
    Dept Neuropathology University Hospital Heidelberg, CCU Neuropathology, German Cancer Center DKFZ
    Heidelberg, Baden-Wurttemberg, Germany

    Andreas von Deimling, MD
    Dept. Neuropathology, University Heidelberg
    CCU Neuropathology, German Cancer Institute (DKFZ), Heidelberg

    Dr. von Deimling is a neuropathologist with special interest in developing tools for brain tumor diagnostics. These tools encompass a wide spectrum such as defining clonal alterations for the diagnosis of specific tumors, generation of mutation-specific antibodies or developing methylation pattern-based tumor classifiers. Aim is to develop international standards suitable for inclusion in WHO guidelines for the classification of tumors. He has received his medical and scientific education in Zurich, Boston and Bonn.

    Disclosure information not submitted.

    Presentation(s):